Atrial fibrillation catheter ablation in females: Same hardware, different findings

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 11, 2011, Pages 1391-1395

  Patel, Dimpi ^a   Armaganijan, Luciana V ^b   Morillo, Carlos A ^c  

^a Dante Pazzanese Institute of Cardiology ^*  (United States)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

atrial fibrillation; catheter ablation; circumferential pulmonary vein ablation; female; gender disparities; pulmonary vein isolation

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DRUG TREATMENT FAILURE; HEART ATRIUM FIBRILLATION; HUMAN; PATIENT SAFETY; SEX DIFFERENCE;

EID: 80955140430     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.119     Document Type: Article

References (26)

1. Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293, 264-240 (2005).
2. Camm AJ, Kirchhof P, Lip GY. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Eur. Heart J. 31(19), 2369-2429 (2010).
3. Patel D, Mohanty P, Di Biase L et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 7, 167-172 (2010).
4. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155, 469-473 (1995).
5. Larsen J, Kadish A. Effects of gender on cardiac arrhythmias. J. Cardiovascular. Electrophysiol. 9, 655-644 (1998).
6. Humphries KH, Kerr CR, Connolly S et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103, 2365-2370 (2001).
7. Paquette M, Roy D, Talajic M et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am. J. Cardiol. 86, 764-768 (2000).
8. Friberg J, Scharling H, Gadsboll N et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study).Am. J. Cardiol. 94, 889-894 (2004).
9. Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol. 49, 572-577 (2007).
10. Fang MC, Singer DE, Chang Y et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors In Atrial fibrillation (ATRIA) study. Circulation 112, 1687-1691 (2005).
11. Rienstra M, Van Veldhuisen DJ, Hagens VE et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J. Am. Coll. Cardiol. 46, 1298-1306 (2005).
12. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N. Engl. J. Med. 23, 1834-1840 (2002).
13. Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmia agents: sex based differences and other issues. Am. J. Cardiol. 91, D39-D44 (2003).
14. Kurokawa J, Tamagawa M, Harada N et al. Acute effects of estrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J. Physiol. 12, 2961-2973 (2008).
15. Rodriguez I, Kilborn MJ, Liu XK et al. Drug-induced QT prolongation in women during the menstrual cycle. JAMA 285, 1322-1326 (2001).
16. Dagres N, Clague J, Breithardt G et al. Significant gender-related differences in radiofrequency catheter ablation therapy. J. Am. Coll. Cardiol. 42, 1103-1107 (2003).
17. Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 7, 257-354 (2006).
18. Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354, 934-941 (2006).
19. Haíssaguerre M, Hocini M, Sanders P et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J. Cardiovasc. Electrophysiol. 16, 1138-1147 (2005).
20. Natale A, Raviele A, Arentz T et al. Venice Chart international consensus document on atrial fibrillation ablation. J. Cardiovasc. Electrophysiol. 18, 560-580 (2007).
21. Roten L, Rimoldi S, Schwick N et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. PACE 32, 622-626 (2009).
22. Forleo G, Tondo C, Luca L et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 9, 613-620 (2007).
23. Lee SH, Tai CT, Hseih MH et al. Predictors of nonpulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implications for catheter ablation. J. Am. Coll. Cardiol. 46, 1056-1059 (2005).
24. Sauer WH, Alonso C, McKernan M et al. Female gender is associated with the presence of nonpulmonary vein triggers of atrial fibrillation (abstr).Circulation 108(Suppl. 5), 617 (2003).
25. Hughes P, Scott C, Bodenham A. Ultrasonography of the femoral vessels on the groin: implications for vascular access. Anaesthesia 55, 1198-1202 (2000).
26. Spragg DD, Dalal D, Cheema A et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J. Cardiovasc. Electrophysiol. 19, 627-631 (2008).